- Home
- Publications
- Publication Search
- Publication Details
Title
The best of both worlds — managing the cancer, saving the bone
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 12, Issue 1, Pages 29-42
Publisher
Springer Nature
Online
2015-10-27
DOI
10.1038/nrendo.2015.185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Task Force Report: Bone Health in Cancer Care
- (2017) Julie R. Gralow et al. Journal of the National Comprehensive Cancer Network
- Use of bevacizumab as a first-line treatment for metastatic breast cancer
- (2015) L. Manso et al. Current Oncology
- Zometa European Study (ZEUS): Another Failed Crusade for the Holy Grail of Prostate Cancer Bone Metastases Prevention?
- (2015) Bertrand Tombal EUROPEAN UROLOGY
- Prevention of Bone Metastases in Patients with High-risk Nonmetastatic Prostate Cancer Treated with Zoledronic Acid: Efficacy and Safety Results of the Zometa European Study (ZEUS)
- (2015) Manfred Wirth et al. EUROPEAN UROLOGY
- Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105
- (2015) Melinda L. Telli et al. JOURNAL OF CLINICAL ONCOLOGY
- The current status future of radiotherapy for spinal bone metastases
- (2015) Yasuo Ejima et al. JOURNAL OF ORTHOPAEDIC SCIENCE
- Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Michael Gnant et al. LANCET
- Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
- (2015) Tilman Todenhöfer et al. International Journal of Endocrinology
- Bone-Immune Cell Crosstalk: Bone Diseases
- (2015) Giorgio Mori et al. Journal of Immunology Research
- Identification of MET and SRC Activation in Melanoma Cell Lines Showing Primary Resistance to PLX4032
- (2015) Elisabetta Vergani et al. NEOPLASIA
- Assessing the benefit of bone-targeted therapies in prostate cancer, is the devil in the end point's definition?
- (2014) B. Tombal ANNALS OF ONCOLOGY
- Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
- (2014) M. R. Smith et al. ANNALS OF ONCOLOGY
- Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer
- (2014) Jeetendra Eswaraka et al. BMC CANCER
- Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: Results from a 2-year multicentre observational study (ZOMAR study)
- (2014) Agustí Barnadas et al. BONE
- Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the “biological window therapy”
- (2014) Chiara Foroni et al. BREAST CANCER RESEARCH AND TREATMENT
- Metastases in Immune-Mediated Dormancy: A New Opportunity for Targeting Cancer
- (2014) I. Romero et al. CANCER RESEARCH
- High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia
- (2014) X. Lin et al. Clinical & Translational Oncology
- Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo
- (2014) P. D. Ottewell et al. CLINICAL CANCER RESEARCH
- miR-154* and miR-379 in the DLK1-DIO3 MicroRNA Mega-Cluster Regulate Epithelial to Mesenchymal Transition and Bone Metastasis of Prostate Cancer
- (2014) M. Gururajan et al. CLINICAL CANCER RESEARCH
- Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
- (2014) Matt Shirley et al. DRUGS
- Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies
- (2014) José O Alemán et al. ENDOCRINE-RELATED CANCER
- RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization
- (2014) Gina Chia-Yi Chu et al. ENDOCRINE-RELATED CANCER
- Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone
- (2014) P. D. Ottewell et al. ENDOCRINE-RELATED CANCER
- A Review of Osteocyte Function and the Emerging Importance of Sclerostin
- (2014) Jocelyn T Compton et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study
- (2014) Matthew R. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
- (2014) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Radiation Therapy in Palliative Care of the Patient With Cancer
- (2014) Stephen T. Lutz et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical Management of Metastatic Long Bone Fractures: Principles and Techniques
- (2014) J. A. Scolaro et al. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
- Serum Biomarkers of Bone Metabolism in Castration-Resistant Prostate Cancer Patients With Skeletal Metastases: Results From SWOG 0421
- (2014) Primo N. Lara et al. JNCI-Journal of the National Cancer Institute
- Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
- (2014) Robert Coleman et al. LANCET ONCOLOGY
- Efficacy of a Cathepsin K Inhibitor in a Preclinical Model for Prevention and Treatment of Breast Cancer Bone Metastasis
- (2014) L. T. Duong et al. MOLECULAR CANCER THERAPEUTICS
- Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia
- (2014) Serkan Kir et al. NATURE
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- Will breast cancer chemoprevention stand on 'solid bone'?
- (2014) Larry J. Suva et al. Nature Reviews Endocrinology
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis
- (2014) J Z Zhou et al. ONCOGENE
- An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control
- (2014) H. Clevers et al. SCIENCE
- An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity
- (2014) U Krause et al. Cell Death & Disease
- The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis
- (2014) Sourik S. Ganguly et al. Frontiers in Oncology
- Current Paradigms for Metastatic Spinal Disease: An Evidence-Based Review
- (2013) P. E. Kaloostian et al. ANNALS OF SURGICAL ONCOLOGY
- The metastatic microenvironment of breast cancer: Clinical implications
- (2013) R.E. Coleman et al. BREAST
- Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer
- (2013) Giuseppe Curigliano et al. BREAST
- Osteoclast-Derived Coupling Factors in Bone Remodeling
- (2013) Kim Henriksen et al. CALCIFIED TISSUE INTERNATIONAL
- Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis
- (2013) Brian Ell et al. CANCER CELL
- Identification of PTHrP(12-48) as a Plasma Biomarker Associated with Breast Cancer Bone Metastasis
- (2013) C. L. Washam et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Interaction among Cells of Bone, Immune System, and Solid Tumors Leads to Bone Metastases
- (2013) Ilaria Roato Clinical & Developmental Immunology
- Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases
- (2013) Leandro Marcelo Martinez et al. CLINICAL & EXPERIMENTAL METASTASIS
- Bone effects of mammalian target of rapamycin (mTOR) inhibition with everolimus
- (2013) Peyman Hadji et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Osteocyte: An Endocrine Cell … and More
- (2013) Sarah L. Dallas et al. ENDOCRINE REVIEWS
- Metabolic regulation of osteoclast differentiation and function
- (2013) Yoriko Indo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial
- (2013) Sydney Bonnick et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer
- (2013) F-L Zhao et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Cisplatin inhibits bone healing during distraction osteogenesis
- (2013) Kimo C. Stine et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Management of Metastatic Bone Disease of the Acetabulum
- (2013) Paul S. Issack et al. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
- Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2
- (2013) M. Gnant et al. JNCI-Journal of the National Cancer Institute
- Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial
- (2013) David I Quinn et al. LANCET ONCOLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of β-catenin activation of the DKK1 promoter in prostate cancer
- (2013) H Zhang et al. ONCOGENE
- Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) A. Valachis et al. ONCOLOGIST
- T Cells Predict Outcome in Zoledronate-Treated Breast Cancer Patients
- (2013) J. L. Welton et al. ONCOLOGIST
- Cancer-associated bone disease
- (2013) R. Rizzoli et al. OSTEOPOROSIS INTERNATIONAL
- Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer
- (2013) K Miller et al. PROSTATE CANCER AND PROSTATIC DISEASES
- An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)
- (2012) R. C. Coombes et al. ANNALS OF ONCOLOGY
- Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
- (2012) R. Coleman et al. ANNALS OF ONCOLOGY
- miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis
- (2012) Karmele Valencia et al. BONE
- Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone
- (2012) Joel B. Nelson et al. CANCER
- Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-Equivalent efficacy, less toxicity, more convenient
- (2012) David D. Howell et al. CANCER
- A Phase II Multicenter Study of Two Different Dosages of Pemetrexed Given in Combination With Cyclophosphamide as First-Line Treatment in Patients With Locally Advanced or Metastatic Breast Cancer
- (2012) Christian Dittrich et al. CANCER INVESTIGATION
- Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases
- (2012) Sten Nilsson et al. Clinical Genitourinary Cancer
- Cost-Effectiveness of Denosumab Versus Zoledronic Acid in the Management of Skeletal Metastases Secondary to Breast Cancer
- (2012) Sonya J. Snedecor et al. CLINICAL THERAPEUTICS
- Sclerostin: a possible target for the management of cancer-induced bone disease
- (2012) Maria Gkotzamanidou et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Osteocyte RANKL: New insights into the control of bone remodeling
- (2012) Jinhu Xiong et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: Insights from a phase IV safety trial
- (2012) Joanne L Welton et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells
- (2012) Lavinia Insalaco et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Alfons JM van den Eertwegh et al. LANCET ONCOLOGY
- Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
- (2012) Alexander HG Paterson et al. LANCET ONCOLOGY
- Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Ravi A Madan et al. LANCET ONCOLOGY
- MicroRNA profiling: approaches and considerations
- (2012) Colin C. Pritchard et al. NATURE REVIEWS GENETICS
- Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice
- (2011) Penelope D. Ottewell et al. BREAST CANCER RESEARCH AND TREATMENT
- Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999–2007)
- (2011) Mellissa Yong et al. BREAST CANCER RESEARCH AND TREATMENT
- The management of cancer pain
- (2011) Judith A. Paice et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biochemical-markers for the diagnosis of bone metastasis: A clinical review
- (2011) Qian Huang et al. Cancer Epidemiology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- MET and VEGF: synergistic targets in castration-resistant prostate cancer
- (2011) Dana T. Aftab et al. Clinical & Translational Oncology
- Bone Metastatic Disease: Taking Aim at New Therapeutic Targets
- (2011) F. Coluzzi et al. CURRENT MEDICINAL CHEMISTRY
- A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II study
- (2011) C. Villanueva et al. EUROPEAN JOURNAL OF CANCER
- Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post-bortezomib monotherapy
- (2011) Evangelos Terpos et al. INTERNATIONAL JOURNAL OF CANCER
- Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline
- (2011) Stephen Lutz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor
- (2011) Gregory A Clines et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Spinal Instability Neoplastic Score: An Analysis of Reliability and Validity From the Spine Oncology Study Group
- (2011) Daryl R. Fourney et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
- (2011) Catherine H. Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis type 1
- (2011) Junrong Ma et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial
- (2011) James Berenson et al. LANCET ONCOLOGY
- Lrp5 functions in bone to regulate bone mass
- (2011) Yajun Cui et al. NATURE MEDICINE
- Matrix-embedded cells control osteoclast formation
- (2011) Jinhu Xiong et al. NATURE MEDICINE
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression
- (2011) Tomoki Nakashima et al. NATURE MEDICINE
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- Update on bone-modifying agents in metastatic breast cancer
- (2011) Larry J. Suva et al. Nature Reviews Endocrinology
- Bone metastasis: mechanisms and therapeutic opportunities
- (2011) Larry J. Suva et al. Nature Reviews Endocrinology
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
- (2011) Asiri R. Wijenayaka et al. PLoS One
- Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt/β-catenin signaling
- (2010) Xiao-lei Zhou et al. ACTA PHARMACOLOGICA SINICA
- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
- (2010) Andrey I. Khramtsov et al. AMERICAN JOURNAL OF PATHOLOGY
- Denosumab and bisphosphonates: Different mechanisms of action and effects
- (2010) Roland Baron et al. BONE
- Anticancer Properties of Zoledronic Acid
- (2010) Jonathan Green et al. CANCER INVESTIGATION
- The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
- (2010) Anders Bonde Jensen et al. Clinical Breast Cancer
- A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients
- (2010) M. Zangari et al. HAEMATOLOGICA
- The amazing osteocyte
- (2010) Lynda F Bonewald JOURNAL OF BONE AND MINERAL RESEARCH
- Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
- (2010) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells
- (2010) Shumin Zhang et al. Molecular Cancer
- CXCR4 and cancer
- (2010) Bungo Furusato et al. PATHOLOGY INTERNATIONAL
- Integrative Genome Comparison of Primary and Metastatic Melanomas
- (2010) Omar Kabbarah et al. PLoS One
- Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases
- (2010) Nanda K. Thudi et al. PROSTATE
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer
- (2009) John W. Smith et al. BREAST CANCER RESEARCH AND TREATMENT
- Surgical Management of Metastatic Bone Disease
- (2009) Jacob Bickels et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Sclerostin and the Unloading of Bone
- (2009) Larry J Suva JOURNAL OF BONE AND MINERAL RESEARCH
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risks and benefits of bisphosphonates
- (2008) R E Coleman BRITISH JOURNAL OF CANCER
- Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
- (2008) Allan Lipton et al. CANCER
- Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer
- (2008) Joel B. Nelson et al. CANCER
- TNFR1 Signaling and IFN-γ Signaling Determine whether T Cells Induce Tumor Dormancy or Promote Multistage Carcinogenesis
- (2008) Nele Müller-Hermelink et al. CANCER CELL
- Bone markers and their prognostic value in metastatic bone disease: Clinical evidence and future directions
- (2008) Robert Coleman et al. CANCER TREATMENT REVIEWS
- Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- (2008) J. E. Lester et al. CLINICAL CANCER RESEARCH
- Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
- (2008) Peyman Hadji CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer‐derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: Implication for breast cancer osteolytic bone metastases
- (2008) Guojun Bu et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336
- (2008) Alvaro Moreno-Aspitia et al. JOURNAL OF CLINICAL ONCOLOGY
- PTH-Related Peptide (PTHrP) in Hypercalcemia
- (2008) G. R. Mundy et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cancer Cell-Derived Clusterin Modulates the Phosphatidylinositol 3'-Kinase-Akt Pathway through Attenuation of Insulin-Like Growth Factor 1 during Serum Deprivation
- (2008) H. Jo et al. MOLECULAR AND CELLULAR BIOLOGY
- ATF6 -Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo
- (2008) D. M. Schewe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started